Bioventus Inc. (BVS)
BVSNASDAQ-GSMedical/Dental Instruments
$11.08
+0.0670 (+0.61%) today
Regular session, Nov 10, 2:27 PM ET
- Market cap
- $933.80m
- P/E
- 14.2
- EPS, last 4 quarters
- $0.7800
- Dividend yield
- –
- Day range
- $10.73 to $11.10
- 52-week range
- $6.47 to $15.89
- Average volume
- 524.5k
- Previous close
- $11.02
Analysts
3 coveringBuy3 buy, 0 hold, 0 sell
Targets a year out average $16.25, +46.6% from here
Earnings
next estimate $0.2400Next report
Dec 2025
+9.1%
Mar 2026
+66.7%
Jun 2026
0.0%
Sep 2026
0.0%
estimate reported, and the surprise
Financials
| Quarter | Dec 2025 | Mar 2026 | Jun 2026 | Sep 2026 |
|---|---|---|---|---|
| Revenue | $157.90m | $132.09m | $153.21m | $142.44m |
| Gross profit | $108.78m | $90.77m | $105.67m | $97.13m |
| Operating income | $19.49m | $8.42m | $19.13m | $9.70m |
| Net income | $14.76m | $3.11m | $33.44m | $5.99m |
Last four quarters: revenue $585.64m, margin 9.8%, free cash flow $84.98m
News
8 latest- Bioventus Reports Higher Q3 Profit, Cuts 2026 Sales Outlook; Stock Down RTTNews · Nov 3, 2026
- Bioventus (BVS) Q3 2026 Earnings Call TranscriptThe Motley Fool · Nov 2, 2026
- Bioventus Q3 Earnings Call HighlightsMarketBeat · Nov 2, 2026
- Bioventus (BVS) Matches Q3 Earnings EstimatesZacks · Nov 2, 2026
- 4 Healthcare Stocks to Safeguard Your Portfolio as Fed Plans Rate HikeZacks · Aug 20, 2026
- Bioventus (BVS) Q2 2026 Earnings Call TranscriptThe Motley Fool · Aug 13, 2026
- Is Bioventus (BVS) Stock Undervalued Right Now?Zacks · Aug 7, 2026
- Biotech Stocks At 52-Week Highs - BVS, TVTX, ODTX, CRL Climb With Q2 Results, ACRS RTTNews · Aug 6, 2026
The company
Bioventus delivers clinically proven, cost-effective products that help people heal quickly and safely. Its mission is to make a difference by helping patients resume and enjoy active lives. The Innovations for Active Healing from Bioventus include offerings for Pain Treatments, Surgical Solutions and Restorative Therapies. Built on a commitment to high quality standards, evidence-based medicine and strong ethical behavior, Bioventus is a trusted partner for physicians worldwide.
- Sector
- Health Care
- Industry
- Medical/Dental Instruments
- Exchange
- NASDAQ-GS
- Region
- North America
- Website
- bioventus.com
Often looked at with it
Figures from Yahoo, Nasdaq (Zacks consensus) and Lighter. Stocks can be minutes behind. Nothing here is advice.